Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

2.

Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.

Muijsers RB, Curran MP, Perry CM.

Drugs. 2002;62(17):2539-67. Review.

PMID:
12421112
3.

Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.

Reynolds NA, Wagstaff AJ, Keam SJ.

Drugs. 2005;65(13):1893-914. Review.

PMID:
16114984
4.

The fixed combination of verapamil SR/trandolapril.

Widimský J.

Expert Opin Pharmacother. 2000 Mar;1(3):515-35. Review.

PMID:
11249535
5.

Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.

Sharma SK, Ruggenenti P, Remuzzi G.

Vasc Health Risk Manag. 2007;3(4):453-65. Review.

6.

[Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].

Krivitzky A, Nguyen G, Gaudouen Y, Legrand M, Cohen R.

Drugs. 1998;56 Suppl 2:31-43. Review. French.

PMID:
9813740
7.

Trandolapril: a newer angiotensin-converting enzyme inhibitor.

Guay DR.

Clin Ther. 2003 Mar;25(3):713-75. Review.

PMID:
12852701
8.

Fixed combination verapamil SR/trandolapril.

Dooley M, Goa KL.

Drugs. 1998 Nov;56(5):837-44; discussion 845-6. Review.

PMID:
9829157
9.
10.

Is cancer related to hypertension or to its treatment?

Lever AF, Hole DJ, Gillis CR, McInnes GT, Meredith PA, Murray LS, Reid JL.

Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):937-46. Review.

PMID:
10423115
12.

Safety profile of the combination of verapamil and trandolapril.

Holzgreve H.

J Hypertens Suppl. 1997 Mar;15(2):S51-3. Review.

PMID:
9218199
13.
14.

Calcium antagonists and atherosclerosis protection in hypertension.

Hernández RH, Armas-Hernández MJ, Velasco M, Israili ZH, Armas-Padilla MC.

Am J Ther. 2003 Nov-Dec;10(6):409-14. Review.

PMID:
14624278
15.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
16.

Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy.

Brouwer RM, Follath F, Bühler FR.

J Cardiovasc Pharmacol. 1985;7 Suppl 4:S38-44. Review.

PMID:
2412010
17.

Trandolapril/verapamil combination in hypertensive diabetic patients.

García Donaire JA, Ruilope LM.

Vasc Health Risk Manag. 2007;3(1):77-82. Review.

18.

Verapamil revisited: a transition in novel drug delivery systems and outcomes.

Prisant LM.

Heart Dis. 2001 Jan-Feb;3(1):55-62. Review.

PMID:
11975770
19.

Coronary benefits of calcium antagonist therapy for patients with hypertension.

Motro M, Shemesh J, Grossman E.

Curr Opin Cardiol. 2001 Nov;16(6):349-55. Review.

PMID:
11704704
20.

Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.

Kuyper LM, Khan NA.

Can J Cardiol. 2014 May;30(5 Suppl):S47-53. doi: 10.1016/j.cjca.2014.01.006. Review.

Items per page

Supplemental Content

Support Center